Tien-En Tan, MBBS(Hons)1,2; Sobha Sivaprasad, DM3; Tien Yin Wong, MBBS, PhD1,2,4
doi : 10.1001/jamaophthalmol.2023.0496
March 2023, Vol 141, No. 3, Pages 222-293
Seong Woo Kim, MD, PhD1; Jae Hui Kim, MD2; Mihyun Choi, MD, PhD1; Sang Joon Lee, MD, PhD3; Jae Pil Shin, MD, PhD4; June Gone Kim, MD, PhD5; Se Woong Kang, MD, PhD6; Kyu Hyung Park, MD, PhD7; for the Korean Retina Society members
doi : 10.1001/jamaophthalmol.2022.5927
Importance Fungal endophthalmitis caused by contaminated medical products is extremely rare; it follows an intractable clinical course with a poor visual prognosis.
Sangil Ahn, BS1; Jitae Shin, PhD1; Su Jeong Song, MD, PhD2; Won Tae Yoon, MD, PhD3; Min Sagong, MD, PhD4; Areum Jeong, MD, PhD4; Joon Hyung Kim, MD5,6; Hyeong Gon Yu, MD, PhD6,7
doi : 10.1001/jamaophthalmol.2022.5928
Importance Until now, other than complex neurologic tests, there have been no readily accessible and reliable indicators of neurologic dysfunction among patients with Parkinson disease (PD).
Hannah L. Walsh, BS1; Abraham Parrish, MA, MILS2; Lauren Hucko, BA1; Jayanth Sridhar, MD3; Kara M. Cavuoto, MD3
doi : 10.1001/jamaophthalmol.2022.6010
Importance The geographic distribution of pediatric ophthalmological care has not been reported on since 2007; understanding this distribution could shed light on potential avenues to increase access, which is a necessary first step in addressing the pediatric ophthalmological needs of underserved areas.
Vahid Mohammadzadeh, MD1; Erica Su, MS2; Massood Mohammadi, MD1; Simon K. Law, MD, PharmD1; Anne L. Coleman, MD, PhD1; Joseph Caprioli, MD1; Robert E. Weiss, PhD2; Kouros Nouri-Mahdavi, MD, MS1
doi : 10.1001/jamaophthalmol.2022.6092
Importance There are scarce data on the association of blood pressure measures with subsequent macular structural rates of change in patients with glaucoma.
Emily H. Jung, AB1; Aaron Lindeke-Myers, MD2; Nieraj Jain, MD3
doi : 10.1001/jamaophthalmol.2022.6093
Importance Prior retrospective studies have provided limited evidence on disease progression following drug cessation in patients with maculopathy associated with pentosan polysulfate (PPS).
David W. Hutton, PhD1; Adam R. Glassman, MS2; Danni Liu, MSPH2; Jennifer K. Sun, MD, MPH3; for the DRCR Retina Network
doi : 10.1001/jamaophthalmol.2022.6142
Importance The DRCR Retina Network Protocol AC showed no significant difference in visual acuity outcomes over 2 years between treatment with aflibercept monotherapy and bevacizumab first with switching to aflibercept for suboptimal response in treating diabetic macular edema (DME).
Lenore von Krusenstiern, MD, PhD1,2; Jiajun Liu, PhD1,3; Eileen Liao, PhD1,4; James A. Gow, MD1; Guo Chen, PhD1,5; Tuyen Ong, MD1,6; Andrew J. Lotery, MD7,8; Assad Jalil, MBBS9; Byron L. Lam, MD10; Robert E. MacLaren, MB, ChB, DPhil11,12; for the XIRIUS Part 1 Study GroupXOLARIS Study Group
doi : 10.1001/jamaophthalmol.2022.6254
Importance X-linked retinitis pigmentosa (XLRP) is a severe cause of early-onset RP in male individuals, characterized by degeneration of photoreceptors, an extinguished electroretinogram, and vision loss.
Alfonso Vasquez-Perez, MD1; Tejal Magan, MD1; Giulio Volpe, MD, MPhil1; Sarah F. Osborne, MD1; Katie McFaul, MD, PhD2; Kaveh Vahdani, MD1
doi : 10.1001/jamaophthalmol.2022.6253
Importance Ophthalmic manifestations occur in less than 5% of patients with human mpox (monkeypox), most commonly presenting with self-limiting conjunctivitis and keratitis. Cases with severe ophthalmic complication are uncommon.
Janan Arslan, MSc, MBiostat, PhD1; Daniel Racoceanu, PhD1; Kurt K. Benke, PhD2
Julius T. Oatts, MD1; Maanasa Indaram, MD1; Alejandra G. de Alba Campomanes, MD, MPH1
Angelo P. Tanna, MD1
Maureen G. Maguire, PhD1,2
Sabyasachi Sengupta, DNB1
Sarah Schimansky, MB BCh BAO1; Omar El Haddad, MB BCh1,2
Mitchell D. Thatcher, BSc1; Laura Z. Wu1; Renatta Varma, MD2
Thamanna Nishath, MSPH1; K. Matthew McKay, MD1; Andrew W. Stacey, MD1
Lusheng Ma, MD1; Jingyi Zhang, MD1; Lei Gao, MD2,3
Do you want to add Medilib to your home screen?